Top
PGBD2 has not been detected as a mutational cancer driver

PGBD2
Ensembl id ENSG00000185220
Mutated samples
Coding Sequence 44 (0.6%)
Protein Affecting 32 (0.5%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all PGBD2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Head and neck squamous cell carcinoma No 6 6 1.60
Lung adenocarcinoma No 8 4 1.02
Cutaneous melanoma No 6 4 1.08
Uterine corpus endometrioid carcinoma No 5 4 1.74
Esophageal carcinoma No 3 3 2.05
Breast carcinoma No 4 2 0.17
Lung squamous cell carcinoma No 4 2 1.15
Glioblastoma multiforme No 2 2 0.53
Pancreas adenocarcinoma No 1 1 0.47
Renal clear cell carcinoma No 1 1 0.24
Thyroid carcinoma No 1 1 0.31
Serous ovarian adenocarcinoma No 1 1 0.32
Colorectal adenocarcinoma No 1 1 0.44
Neuroblastoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence